Veonet is positioned as the forefront pan-European network of ophthalmological clinics. With its headquarters in Germany, the company has rapidly expanded since its inception in 2021, now encompassing over 250 clinics across five countries.
Treating over 2.0 million patients annually, Veonet boasts a robust collaboration with all health insurance providers and supports national healthcare services. The clinics conduct roughly 450,000 eye surgeries and 2.0 million ophthalmological procedures each year, making them a leading provider of high-quality eye care.
The founders, reputed ophthalmologists themselves, have infused their vision of shared expertise and best practices into the company's DNA, ensuring continuous improvement and professional growth. While yet to disclose any recent investments, Veonet presents itself as a promising opportunity in the Health Care industry for investors seeking to engage with a company that is making significant strides in specialized medical care.